221 related articles for article (PubMed ID: 25758335)
1. Infantile onset Vanishing White Matter disease associated with a novel EIF2B5 variant, remarkably long life span, severe epilepsy, and hypopituitarism.
Woody AL; Hsieh DT; McIver HK; Thomas LP; Rohena L
Am J Med Genet A; 2015 Apr; 167A(4):826-30. PubMed ID: 25758335
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of mutations for the diagnosis of vanishing white matter disease.
Scali O; Di Perri C; Federico A
Neurol Sci; 2006 Sep; 27(4):271-7. PubMed ID: 16998732
[TBL] [Abstract][Full Text] [Related]
3. [CACH/VWM syndrome and leucodystrophies related to EIF2B mutations].
Labauge P; Fogli A; Niel F; Rodriguez D; Boespflug-Tanguy O
Rev Neurol (Paris); 2007 Sep; 163(8-9):793-9. PubMed ID: 17878805
[TBL] [Abstract][Full Text] [Related]
4. A Japanese girl with an early-infantile onset vanishing white matter disease resembling Cree leukoencephalopathy.
Takano K; Tsuyusaki Y; Sato M; Takagi M; Anzai R; Okuda M; Iai M; Yamashita S; Okabe T; Aida N; Tsurusaki Y; Saitsu H; Matsumoto N; Osaka H
Brain Dev; 2015 Jun; 37(6):638-42. PubMed ID: 25457085
[TBL] [Abstract][Full Text] [Related]
5. [Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases].
Carra-Dalliere C; Horzinski L; Ayrignac X; Vukusic S; Rodriguez D; Mauguiere F; Peter L; Goizet C; Bouhour F; Denier C; Confavreux C; Obadia M; Blanc F; de Seze J; Sedel F; Guennoc AM; Sartori E; Laplaud D; Antoine JC; Fogli A; Boespflug-Tanguy O; Labauge P
Rev Neurol (Paris); 2011 Nov; 167(11):802-11. PubMed ID: 21676421
[TBL] [Abstract][Full Text] [Related]
6. Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up.
Bektaş G; Yeşil G; Özkan MU; Yıldız EP; Uzunhan TA; Çalışkan M
Clin Neurol Neurosurg; 2018 Aug; 171():190-193. PubMed ID: 29933199
[TBL] [Abstract][Full Text] [Related]
7. Leukoencephalopathy with vanishing white matter due to homozygous EIF2B2 gene mutation. First Polish cases.
Mierzewska H; van der Knaap MS; Scheper GC; Jurkiewicz E; Schmidt-Sidor B; Szymańska K
Folia Neuropathol; 2006; 44(2):144-8. PubMed ID: 16823698
[TBL] [Abstract][Full Text] [Related]
8. Identification of ten novel mutations in patients with eIF2B-related disorders.
Ohlenbusch A; Henneke M; Brockmann K; Goerg M; Hanefeld F; Kohlschütter A; Gärtner J
Hum Mutat; 2005 Apr; 25(4):411. PubMed ID: 15776425
[TBL] [Abstract][Full Text] [Related]
9. The large spectrum of eIF2B-related diseases.
Fogli A; Boespflug-Tanguy O
Biochem Soc Trans; 2006 Feb; 34(Pt 1):22-9. PubMed ID: 16246171
[TBL] [Abstract][Full Text] [Related]
10. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases.
Labauge P; Horzinski L; Ayrignac X; Blanc P; Vukusic S; Rodriguez D; Mauguiere F; Peter L; Goizet C; Bouhour F; Denier C; Confavreux C; Obadia M; Blanc F; de Sèze J; Fogli A; Boespflug-Tanguy O
Brain; 2009 Aug; 132(Pt 8):2161-9. PubMed ID: 19625339
[TBL] [Abstract][Full Text] [Related]
11. The effect of genotype on the natural history of eIF2B-related leukodystrophies.
Fogli A; Schiffmann R; Bertini E; Ughetto S; Combes P; Eymard-Pierre E; Kaneski CR; Pineda M; Troncoso M; Uziel G; Surtees R; Pugin D; Chaunu MP; Rodriguez D; Boespflug-Tanguy O
Neurology; 2004 May; 62(9):1509-17. PubMed ID: 15136673
[TBL] [Abstract][Full Text] [Related]
12. Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patients.
Kantor L; Harding HP; Ron D; Schiffmann R; Kaneski CR; Kimball SR; Elroy-Stein O
Hum Genet; 2005 Oct; 118(1):99-106. PubMed ID: 16041584
[TBL] [Abstract][Full Text] [Related]
13. A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation.
Fogli A; Dionisi-Vici C; Deodato F; Bartuli A; Boespflug-Tanguy O; Bertini E
Neurology; 2002 Dec; 59(12):1966-8. PubMed ID: 12499492
[TBL] [Abstract][Full Text] [Related]
14. Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders.
Horzinski L; Huyghe A; Cardoso MC; Gonthier C; Ouchchane L; Schiffmann R; Blanc P; Boespflug-Tanguy O; Fogli A
PLoS One; 2009 Dec; 4(12):e8318. PubMed ID: 20016818
[TBL] [Abstract][Full Text] [Related]
15. Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model.
Terumitsu-Tsujita M; Kitaura H; Miura I; Kiyama Y; Goto F; Muraki Y; Ominato S; Hara N; Simankova A; Bizen N; Kashiwagi K; Ito T; Toyoshima Y; Kakita A; Manabe T; Wakana S; Takebayashi H; Igarashi H
J Neurochem; 2020 Jul; 154(1):25-40. PubMed ID: 31587290
[TBL] [Abstract][Full Text] [Related]
16. Vanishing white matter disease with different faces.
Güngör G; Güngör O; Çakmaklı S; Maraş Genç H; İnce H; Yeşil G; Dilber C; Aydın K
Childs Nerv Syst; 2020 Feb; 36(2):353-361. PubMed ID: 31385086
[TBL] [Abstract][Full Text] [Related]
17. Vanishing white matter disease associated with progressive macrocephaly.
Pineda M; R-Palmero A; Baquero M; O'Callaghan M; Aracil A; van der Knaap M; Scheper GC
Neuropediatrics; 2008 Feb; 39(1):29-32. PubMed ID: 18504679
[TBL] [Abstract][Full Text] [Related]
18. Leukoencephalopathy with vanishing white matter: a review.
Bugiani M; Boor I; Powers JM; Scheper GC; van der Knaap MS
J Neuropathol Exp Neurol; 2010 Oct; 69(10):987-96. PubMed ID: 20838246
[TBL] [Abstract][Full Text] [Related]
19. Dominant form of vanishing white matter-like leukoencephalopathy.
Labauge P; Fogli A; Castelnovo G; Le Bayon A; Horzinski L; Nicoli F; Cozzone P; Pagès M; Briere C; Marty-Double C; Delhaume O; Gelot A; Boespflug-Tanguy O; Rodriguez D
Ann Neurol; 2005 Oct; 58(4):634-9. PubMed ID: 16047349
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
